Biolinq has developed a micro-array of biosensors to measure interstitial fluid glucose levels just under the surface of the skin, leveraging innovation from the semiconductor industry to miniaturize electrochemical sensors designed for precision manufacturing and significant scale. “Biolinq is a genuine game-changer – with a product platform designed to make continuous sensing simple and more accessible. Biolinq is a medical device company developing a wearable biosensor platform that measures biomarkers important to the management of many clinical conditions, including diabetes.